We are live on ! Find out more
SCM

Scopia Capital Management Portfolio holdings

AUM $146M
1-Year Est. Return 25.93%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+25.93%
3 Year Est. Return
+30.87%
5 Year Est. Return
+45.28%
10 Year Est. Return
+379.83%
AUM
$5.2B
AUM Growth
-$526M
Cap. Flow
-$810M
Cap. Flow %
-15.58%
Top 10 Hldgs %
61.55%
Holding
40
New
2
Increased
12
Reduced
16
Closed
2

Top Buys

Rank Stock Value
1
ARRS
ARRIS International plc Ordinary Shares
ARRS
+$125M
2
ZGNX
Zogenix, Inc.
ZGNX
+$91.6M
3
VST icon
Vistra
VST
+$84.5M
4
JD icon
JD.com
JD
+$68.6M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$54.2M

Top Sells

Rank Stock Value
1
OPTU
Optimum Communications Inc
OPTU
+$172M
2
W icon
Wayfair
W
+$156M
3
BIDU icon
Baidu
BIDU
+$123M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$83M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$79.4M

Sector Composition

Rank Sector Weight
1 Healthcare 32%
2 Industrials 15.06%
3 Real Estate 13.9%
4 Technology 6.95%
5 Consumer Discretionary 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCE.A
1
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$544M 10.47%
21,672,157
-415,646
-2% -$10.1M
SPR
2
DELISTED
Spirit AeroSystems
SPR
$491M 9.46%
5,361,113
+310,584
+6% +$27.3M
ITRI icon
3
Itron
ITRI
$4.54B
$347M 6.67%
5,400,168
-84,721
-2% -$5.34M
VST icon
4
Vistra
VST
$47.4B
$300M 5.78%
12,071,361
+3,672,849
+44% +$84.5M
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$289M 5.56%
14,762,354
+2,850,064
+24% +$54.2M
ZGNX
6
DELISTED
Zogenix, Inc.
ZGNX
$263M 5.07%
5,306,514
+1,798,786
+51% +$91.6M
JCI icon
7
Johnson Controls International
JCI
$92.2B
$262M 5.04%
7,478,853
-17,775
-0.2% -$655K
GWPH
8
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$257M 4.94%
1,487,307
-550,818
-27% -$79.4M
ARRS
9
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$234M 4.5%
9,000,000
+4,892,434
+119% +$125M
SPY icon
10
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$211M 4.06%
726,100
-666,000
-48% -$190M
TVTX icon
11
Travere Therapeutics
TVTX
$5.78B
$187M 3.6%
6,519,425
– –
JD icon
12
JD.com
JD
$44.5B
$186M 3.59%
7,143,928
+2,094,656
+41% +$68.6M
ISBC
13
DELISTED
Investors Bancorp, Inc.
ISBC
$174M 3.35%
14,190,051
+3,168,837
+29% +$40.3M
SRC
14
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$151M 2.9%
3,738,717
-1,122,370
-23% -$46.5M
ACOR
15
DELISTED
Acorda Therapeutics
ACOR
$140M 2.69%
59,225
-4,413
-7% -$13.7M
MNK
16
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$138M 2.67%
4,724,581
-2,947,631
-38% -$83M
W icon
17
Wayfair
W
$14.6B
$132M 2.54%
892,600
-1,229,595
-58% -$156M
EQT icon
18
EQT Corp
EQT
$32.3B
$105M 2.02%
4,360,360
+938,977
+27% +$25.9M
CNMD icon
19
CONMED
CNMD
$1.47B
$95.4M 1.84%
1,204,851
-519,194
-30% -$40.2M
IWM icon
20
PUT
iShares Russell 2000 ETF
IWM
$83B
$85.3M 1.64%
506,200
-2,090,500
-81% -$353M
WFT
21
DELISTED
Weatherford International plc
WFT
$84.1M 1.62%
31,019,881
+4,340,119
+16% +$12.7M
PTCT icon
22
PTC Therapeutics
PTCT
$6.12B
$76M 1.46%
1,616,998
-686,343
-30% -$28.4M
AUD
23
DELISTED
Audacy, Inc.
AUD
$62.8M 1.21%
7,950,651
-2,373,950
-23% -$18.4M
THC icon
24
Tenet Healthcare
THC
$21.1B
$52.8M 1.02%
1,856,285
+48
+0% +$1.58K
LJPC
25
DELISTED
La Jolla Pharmaceutical Company
LJPC
$52.1M 1%
2,590,212
+7,042
+0.3% +$184K
1
2

Similar funds

AWM
Apex Wealth Management Bedford, New Hampshire $146M AUM 15.52% 1-Year Est. Return
SIM
Sentry Investment Management Stevens Point, Wisconsin $146M AUM 23.67% 1-Year Est. Return
TA
TRB Advisors New York $146M AUM 3.71% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
AFM
Aspetuck Financial Management Westport, Connecticut $146M AUM 33.29% 1-Year Est. Return
ECM
Endure Capital Management Austin, Texas $146M AUM
CWM
Copia Wealth Management Bend, Oregon $146M AUM 20.84% 1-Year Est. Return
CCM
Crestwood Capital Management New York $146M AUM 34.13% 1-Year Est. Return

Scopia Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Scopia Capital Management held 40 positions worth $5.2B, down 9.2% from $5.72B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Scopia Capital Management withdrew a net $810M in Q3 2018, closing 2 positions and reducing 16 holdings. Its most notable exit was Optimum Communications Inc, an estimated $172M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Industrials and Real Estate.

Against the trend, Scopia Capital Management opened a new position in Y-mAbs Therapeutics worth $42.2M.

  • Scopia Capital Management's largest Q3 2018 buy was Y-mAbs Therapeutics: 1,587,566 shares worth $42.2M.
  • Scopia Capital Management added most to ARRIS International plc Ordinary Shares in Q3 2018, an estimated $125M increase.
  • Scopia Capital Management's biggest Q3 2018 reduction was Wayfair, cutting an estimated $156M.
  • Scopia Capital Management fully exited Optimum Communications Inc in Q3 2018, selling an estimated $172M.
  • Scopia Capital Management's ten largest holdings make up 62% of its $5.2B portfolio in Q3 2018.
  • Scopia Capital Management opened 2 new positions and closed 2 in Q3 2018.
  • Scopia Capital Management's portfolio value fell 9.2% quarter-over-quarter to $5.2B.

Based on Scopia Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.